The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson Abiomed Impella RP heart ...

Kent Elastomer Products has spent over 60 years carving out a niche for itself in latex dip tubing. President John Danes ...

We recently compiled a list of the The 10 Worst-Performing Stocks on Monday. In this article, we are going to take a look at where BridgeBio Pharma Inc. (NASDAQ:BBIO) stands against the other ...

While this is a fun, satisfying sight to behold, it's unfortunately temporary. Known as a muscle pump, this type of instant muscle growth occurs for a reason. But does it actually have any ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Jan. 28, 2025 (GLOBE NEWSWIRE) -- Helicore Biopharma Inc., a biopharmaceutical company focused on the discovery and development of first-in-class glucose-dependent insulinotropic peptide (GIP ...

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments intended to boost prescriptions. Recently, Pfizer found itself in the ...

Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new ...

After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we have made the difficult decision to close Outsourcing Pharma and BioPharma Reporter. It has ...

Biomaterials are those materials — be it natural or synthetic, alive or lifeless, and usually made of multiple components — that interact with biological systems. Biomaterials are often used ...

Will competition from China put pressure on young U.S. drugmakers? The answers will shape the industry’s fortunes this year, as BioPharma Dive details in the stories below. Read on for a look at ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...